Antimalarials should target female parasites


Disease causing organisms are notorious for their rapid evolution and their quick aquisition of resistance to the drugs used to fight them. However, in the case of the disease causing parasites Plasmodium, scientists have shown that it is the males of the species that really race ahead in the evolutionary race.

Sex is a key driver for evolution but this tends to be overlooked when looking at unicellular life forms, said Sarah Reece of Edinburgh University and her colleagues in their paper. The Plasmodium parasite, unlike humans, for example, does not have different genes coding for different sexes. Instead, sex is solely determined by which genes are expressed. Reece and colleagues placed the parasites under evolutionary pressure and observed that it was the male-biased genes that were the fast adaptors. The finding suggests that to help prevent resistance, new antimalarials should target the slower evolving female genes, or those that are expressed by both sexes.


Related Content

Promising compound offers single dose knock-out for malaria

17 June 2015 Research

news image

Candidate antimalarial drug halt parasite protein synthesis and will enter human trials in a year

New antimalarial drug class resists resistance

21 March 2013 Research

news image

Drug candidate looks promising as scientists draw on past failures to address toxicity problems

Most Commented

Rechargeable first for promising battery tech

6 May 2016 Research

news image

New cathode material makes for energetic, rechargeable sodium–carbon dioxide batteries that could power Mars vehicles

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels